Abstract:Expression quantitative trait loci (eQTL) analysis is useful for identifying genetic variants correlated with gene expression, however, it cannot distinguish between causal and nearby non-functional variants. Because the majority of disease-associated SNPs are located in regulatory regions, they can impact allele-specific binding (ASB) of transcription factors and result in differential expression of the target gene alleles. In this study, our aim was to identify functional single-nucleotide polymorphisms (SNPs) that alter transcriptional regulation and thus, potentially impact cellular function. Here, we present regSNPs-ASB, a generalized linear model-based approach to identify regulatory SNPs that are located in transcription factor binding sites. The input for this model includes ATAC-seq (assay for transposase-accessible chromatin with high-throughput sequencing) raw read counts from heterozygous loci, where differential transposase-cleavage patterns between two alleles indicate preferential transcription factor binding to one of the alleles. Using regSNPs-ASB, we identified 53 regulatory SNPs in human MCF-7 breast cancer cells and 125 regulatory SNPs in human mesenchymal stem cells (MSC). By integrating the regSNPs-ASB output with RNA-seq experimental data and publicly available chromatin interaction data from MCF-7 cells, we found that these 53 regulatory SNPs were associated with 74 potential target genes and that 32 (43%) of these genes showed significant allele-specific expression. By comparing all of the MCF-7 and MSC regulatory SNPs to the eQTLs in the Genome-Tissue Expression (GTEx) Project database, we found that 30% (16/53) of the regulatory SNPs in MCF-7 and 43% (52/122) of the regulatory SNPs in MSC were also in eQTL regions. The enrichment of regulatory SNPs in eQTLs indicated that many of them are likely responsible for allelic differences in gene expression (chi-square test, p-value < 0.01). In summary, we conclude that regSNPs-ASB is a useful tool for identifying causal variants from ATAC-seq data. This new computational tool will enable efficient prioritization of genetic variants identified as eQTL for further studies to validate their causal regulatory function. Ultimately, identifying causal genetic variants will further our understanding of the underlying molecular mechanisms of disease and the eventual development of potential therapeutic targets.

Identification of Regulatory Variants of Carboxylesterase 1 (CES1): A Proof‐of‐concept Study for the Application of the Allele‐Specific Protein Expression (ASPE) Assay in Identifying Cis‐acting Regulatory Genetic Polymorphisms

Determining Allele-Specific Protein Expression (ASPE) Using a QconCAT-Based Proteomics Method: a Novel Approach to Identify Cis-acting Genetic Variants

Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators

Cisase: a Likelihood-Based Method for Detecting Putative Cis-Regulated Allele-Specific Expression in RNA Sequencing Data.

Response to the comments on "Determining Allele-Specific Protein Expression (ASPE) Using a Novel QconCAT-Based Proteomics Method".

CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors

Genome-Wide Identification of Allele-Specific Effects on Gene Expression for Single and Multiple Individuals

Sensing Carboxylesterase 1 in Living Systems by a Practical and Isoform-Specific Fluorescent Probe

Response to the Comments on “Determining Allele-Specific Protein Expression (ASPE) Using a Novel Quantitative Concatamer Proteomics Method”

Regsnps-Asb: A Computational Framework for Identifying Allele-Specific Transcription Factor Binding from ATAC-seq Data

Abstract 076: the Blood Pressure-associated Non-coding Single Nucleotide Polymorphism Rs28451064 Influences Gene Expression in Human Endothelial Cells

High-throughput characterization of genetic effects on DNA-protein binding and gene transcription

Recommendations for Accurate Resolution of Gene and Isoform Allele-Specific Expression in RNA-Seq Data

Establishment of Microrna, Transcript and Protein Regulatory Networks in Alport Syndrome Induced Pluripotent Stem Cells

GeneiASE: Detection of condition-dependent and static allele-specific expression from RNA-seq data without haplotype information

High-throughput Screening and CRISPR-Cas9 Modeling of Causal Lipid-associated Expression Quantitative Trait Locus Variants

Abstract 242: Functional Characterization of a Cis-eQTL Locus for Plasma Cholesterol Using CRISPR/Cas Genome Editing in Human Pluripotent Stem Cells

Polymorphisms Affecting Gene Transcription and Mrna Processing in Pharmacogenetic Candidate Genes: Detection Through Allelic Expression Imbalance in Human Target Tissues

Allelic Expression of Deleterious Protein-Coding Variants Across Human Tissues

Comparing Computational Methods for Identification of Allele-Specific Expression Based on Next Generation Sequencing Data.

Carboxylesterases: Pharmacological Inhibition Regulated Expression and Transcriptional Involvement of Nuclear Receptors and other Transcription Factors